PLATELET INDICES FOR PREDICTING LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION
DOI:
https://doi.org/10.24293/ijcpml.v25i1.1487Keywords:
Platelet count, MPV, PDW, fibrosis, chronic hepatitis BAbstract
Chronic Hepatitis B involves liver parenchymal destruction leading to fibrosis. Decreased serum thrombopoietin associated with liver cell failure is thought as the leading cause of thrombocytopenia. Mean Platelet Volume (MPV) and Platelet Distribution Width (PDW) describe platelet size and degree of variation in platelet size respectively. The researchers intended to investigate whether platelet count, MPV, and PDW were variables to determine the severity of liver fibrosis in chronic hepatitis B patients. An observational study was carried out at the Dr. Wahidin Sudirohusodo Hospital Makassar from January 2015 until December 2016. A total of 100 chronic hepatitis B patients with negative HBeAg who underwent Fibroscan and complete blood count test were included in this study. A total of 100 chronic hepatitis B patients comprising, 11 with severe liver fibrosis, 16 with moderate liver fibrosis, 46 with mild liver fibrosis, and 27 with normal liver. There were significant differences in platelet count and MPV among liver fibrosis groups with p-value <0.001 and 0.046 respectively. No significant difference was observed for PDW among liver fibrosis groups (p=0.131). This study showed that platelet count and MPV were significantly different among the normal group, mild liver fibrosis group, moderate liver fibrosis group and severe liver fibrosis group in chronic hepatitis B patients. The researchers recommend to carry out studies with larger samples in number and distributed more evenly.
Downloads
References
WHO. Background in guidelines for the prevention, care, and treatment of persons with chronic hepatitis B infection. Switzerland, World Health Organization, 2015; 14-24.
Kementrian Kesehatan RI. Situasi dan analisis hepatitis dalam pusat data dan informasi kementrian kesehatan RI. Jakarta Selatan, Kementrian Kesehatan RI, 2014; 1-6.
Gani AR, Hasan I, Djumhana A, Setiawan PB. Epidemiologi hepatitis B in konsensus nasional penatalaksanaan hepatitis B. Jakarta, Perhimpunan Peneliti Hati Indonesia. 2012; 1.
Yano Y, Utsumi T, Lusida MI, Hayashi Y. Hepatitis B virus infection in Indonesia in World Journal of Gastroenterology. California, Baishideng Publishing Group Inc. 2015; 10714-20.
Boesecke C, Wasmuth JC. Hepatitis B in hepatology. A clinical textbook. 3rd Ed., Germany, Flying Publishers, 2012; 34-43.
Wirawan R. Penilaian parameter hematologi umum dan parameter tambahan dengan alat Sysmex XE-Series. Jakarta, Fakultas Kedokteran Universitas Indonesia. 2013; 18-24.
Hoffman R, Benz EJ, Shattil AJ, Furie B, Cohen HJ, et al. Interpretation of automated blood cells analysis in hematology: Basic principles and practice. 3rd Ed., Pennsylvania, Churchill Livingstone Inc. 2000; 2470-2.
Ceylan B, Mete B, Fincanci M, Aslan T, Akkoyunlu Y, et al. A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection. Central European Journal of Medicine. Springer, 2013; 453-60.
Karagoz E, Ulcay A, Tanoglu A, Kara M, Turhan V, et al. Clinical usefulness of mean platelet volume and red cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients. European Journal of Gastroenterology and Hepatology, Lippincott Williams & Wilkins, 2014; 26(12): 1320-4.
Hu Y, Lou Y, Chen Y, Mao W. Evaluation of mean platelet volume in patients with hepatitis B virus infection. International Journal of Clinical Experiment in Medicine. 2014; 7(11): 4207-13.
Wahyuni RD. Analisis derajat fibrosis hati dengan FibroScan, indeks FIB4, King's Score dan APRI Score pada penyakit hepatitis kronis. Jurnal Kesehatan Tadulako, 2016; 2(2): 42-5.
Ekiz F, Yuksel O, Kocak E, Yilmaz B, Altinbas, et al. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B. Journal of Clinical Laboratory Analysis, 2014; 25(3): 162-5.
